Elanco and Bayer divestment updates
So far in 2020, Elanco and Bayer have agreed to sell: Vecoxan (diclazuril), an oral drench for the prevention and treatment of coccidiosis in calves and lambs, to Merck. Osurnia (florfenicol, terbinafine, betamethasone acetate), for the treatment of otitis externa…